Status:
COMPLETED
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
Lead Sponsor:
Novartis
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will assess the effectiveness and safety of different combination antihypertensive treatments in patients with severe hypertension
Eligibility Criteria
Inclusion
- Patients with severe hypertension
Exclusion
- History of stroke, myocardial infarction, heart failure, chest pain, abnormal heart rhythm
- Liver, kidney, or pancreas disease
- Insulin dependent diabetes
- Allergy to certain medications used to treat high blood pressure
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2005
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00171535
Start Date
October 1 2004
End Date
April 1 2005
Last Update
November 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis Pharmaceuticals
East Hanover, New Jersey, United States, 07936